. . . . . . . "[MDM2 amplification in soft tissue sarcoma patients was associated with a prognosis better than that of patients without the amplification.of the tumors with an MDM2 amplification, 40% also experienced loss of heterozygosity at 12q14-15.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:29+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .